Evidence map›Paper›PMID 26527680›Full record

ArticleThe Journal of biological chemistry2015

Streptococcal 5'-Nucleotidase A (S5nA), a Novel Streptococcus pyogenes Virulence Factor That Facilitates Immune Evasion.

Lisa Zheng, Adrina Khemlani, Natalie Lorenz, Jacelyn M S Loh, Ries J Langley, Thomas Proft

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Infection and immunity · 2026
    Article
  2. Review
  3. Pleiotropic functions of CpdB in Bacillus anthracis.World journal of microbiology & biotechnology · 2025
    Article
  4. Virulence · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Immunomodulating Enzymes fromMicroorganisms · 2024
    Review
  9. Article
  10. Article
  11. Frontiers in cellular and infection microbiology · 2023
    Article
  12. Frontiers in immunology · 2022
    Article
  13. Purinergic Signalling in Group AFrontiers in immunology · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Peptidomics Analysis of Virulent Peptides Involved inAnimals : an open access journal from MDPI · 2021
    Article
  18. Deciphering the Role ofFrontiers in immunology · 2021
    Article
  19. Article
  20. Functional Analysis of Two NovelMicroorganisms · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Lisa ZhengFrom the Department of Molecular Medicine and Pathology, School of Medical Sciences, and.
Adrina KhemlaniFrom the Department of Molecular Medicine and Pathology, School of Medical Sciences, and.
Natalie LorenzFrom the Department of Molecular Medicine and Pathology, School of Medical Sciences, and the Maurice Wilkins Center, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-5480-1714
Jacelyn M S LohFrom the Department of Molecular Medicine and Pathology, School of Medical Sciences, and the Maurice Wilkins Center, University of Auckland, Auckland, New Zealand.ORCID http://orcid.org/0000-0002-9428-1215
Ries J LangleyFrom the Department of Molecular Medicine and Pathology, School of Medical Sciences, and the Maurice Wilkins Center, University of Auckland, Auckland, New Zealand.
Thomas ProftFrom the Department of Molecular Medicine and Pathology, School of Medical Sciences, and the Maurice Wilkins Center, University of Auckland, Auckland, New Zealand t.proft@auckland.ac.nz.ORCID http://orcid.org/0000-0002-9275-5042
University of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pyogenes is an important human pathogen that causes a wide range of diseases. Using bioinformatics analysis of the complete S. pyogenes strain SF370 genome, we have identified a novel S. pyogenes virulence factor, which we termed streptococcal 5'-nucleotidase A (S5nA). A recombinant form of S5nA hydrolyzed AMP and ADP, but not ATP, to generate the immunomodulatory molecule adenosine. Michaelis-Menten kinetics revealed a Km of 169 μm and a Vmax of 7550 nmol/mg/min for the substrate AMP. Furthermore, recombinant S5nA acted synergistically with S. pyogenes nuclease A to generate macrophage-toxic deoxyadenosine from DNA. The enzyme showed optimal activity between pH 5 and pH 6.5 and between 37 and 47 °C. Like other 5'-nucleotidases, S5nA requires divalent cations and was active in the presence of Mg(2+), Ca(2+), or Mn(2+). However, Zn(2+) inhibited the enzymatic activity. Structural modeling combined with mutational analysis revealed a highly conserved catalytic dyad as well as conserved substrate and cation-binding sites. Recombinant S5nA significantly increased the survival of the non-pathogenic bacterium Lactococcus lactis during a human whole blood killing assay in a dose-dependent manner, suggesting a role as an S. pyogenes virulence factor. In conclusion, we have identified a novel S. pyogenes enzyme with 5'-nucleotidase activity and immune evasion properties.

Indexed as

Immune EvasionBacterial ProteinsBlood Bactericidal ActivityHumansLactococcus lactisMacrophagesMicrobial ViabilityN-Glycosyl HydrolasesStreptococcus pyogenesVirulence FactorsBacterial ProteinsN-Glycosyl HydrolasesVirulence Factorsadenosineenzyme catalysisgroup A streptococcusimmune evasionmodel structuremutation analysisnucleoside/nucleotide metabolismStreptococcus pyogenes (S. pyogenes)virulence factor

Identifiers

PMID26527680
PMCPMC4692236
OpenAlexW2281015576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.